Safety of smoking cessation drugs

Medical Letter on Drugs and Therapeutics

Volumn 51, Issue 1319, 2009, Pages 65-

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; PLACEBO; VARENICLINE;

ABNORMAL DREAMING; AGITATION; CLINICAL TRIAL; CONSTIPATION; DEPRESSION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FLATULENCE; FOOD AND DRUG ADMINISTRATION; HEADACHE; HOSTILITY; HUMAN; INSOMNIA; MENTAL DISEASE; MONOTHERAPY; NAUSEA; SHORT SURVEY; SIDE EFFECT; SLEEP DISORDER; SMOKING CESSATION; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE; TOBACCO DEPENDENCE; TREATMENT DURATION; VOMITING; WEIGHT GAIN; XEROSTOMIA;

EID: 70349932483     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (5)

1. Drugs for tobacco dependence. Treat Guidel Med Lett 2008; 6:61.
2. DE Jorenby et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 1999; 340:685.
3. MC Fiore et al. Treating tobacco use and dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service. May 2008; available at www.surgeongeneral.gov/ tobacco/. Accessed August 17, 2009.
4. S Tonstad et al. Effect of maintenance therapy with varenicline on smoking cessation: A randomized controlled trial. JAMA 2006; 296:64.
5. FDA Drug Safety Newsletter 2009; 2:23.